302
- Ouimet JM, Pope JE, Gutmanis I, Koval J. Work disability in scleroderma is greater than in
rheumatoid arthritis and is predicted by high HAQ scores. Open Rheumatol J. 2008;2:44–52.
doi: 10.2174/1874312900802010044. - Bassel M, Hudson M, Taillefer SS, et al. Frequency and impact of symptoms experienced by
patients with systemic sclerosis: results from a Canadian National Survey. Rheumatology
(Oxford). 2010;50:762–7. - Schnitzer M, Hudson M, Baron M, Steele R, Canadian Scleroderma Research Group.
Disability in systemic sclerosis—a longitudinal observational study. J Rheumatol.
2011;38(4):685–92. doi: 10.3899/jrheum.100635. - Leroy EC, Black C, Fleischmajer R, et al. Scleroderma (systemic sclerosis): classifi cation,
subsets and pathogenesis. J Rheumatol. 1988;15:202–5. - Seibold J. Connective tissue diseases characterized by fi brosis. In: Ruddy S, Harris Jr ED,
Sledge CB, editors. Textbook of rheumatology. Philadelphia: WB Saunders; 2001.
p. 1133–59. - Wigley F, Systemic SB. Clinical features. In: Klippel JH, editor. Primer on the rheumatic
diseases. Atlanta: The Arthritis Foundation; 2001. p. 357–64. - Medsger Jr TA. Natural history of systemic sclerosis and the assessment of disease activity,
severity, functional status, and psychologic well-being. Rheum Dis Clin North Am.
2003;29:255–73. - Hudson M, Thombs BD, Steele R, Panopalis P, Newton E, Baron M, Canadian Scleroderma
Research Group. Quality of life in patients with systemic sclerosis compared to the general
population and patients with other chronic conditions. J Rheumatol. 2009;36:768–72.
doi: 10.3899/jrheum.080281. - Sekhon S, Pope J, Canadian Scleroderma Research Group (CSRG), Baron M. The Minimally
Important Difference (MID) for patient centered outcomes including Health Assessment
Questionnaire (HAQ), Fatigue, Pain, Sleep, Global VAS and SF-36 in Scleroderma (SSc).
J Rheumatol. 2010;37(3):591–8. doi: 10.3899/jrheum.090375. - Varga J, Denton CP, Wigley FM, editors. Scleroderma: from pathogenesis to comprehensive
management. New York: Springer; 2012. doi: 10.1007/978-1-4419-5774-0_7. - Schieir O, Thombs BD, Hudson M, Boivin JF, Steele R, Bernatsky S, Hanley J, Baron M,
Canadian Scleroderma Research Group. Prevalence, severity, and clinical correlates of pain
in patients with systemic sclerosis. Arthritis Care Res (Hoboken). 2010;62(3):409–17.
doi: 10.1002/acr.20108. - El-Baalbaki G, Razykov I, Hudson M, Bassel M, Baron M, Thombs BD, Canadian
Scleroderma Research Group. Association of pruritus with quality of life and disability in
systemic sclerosis. Arthritis Care Res (Hoboken). 2010;62(10):1489–95. doi: 10.1002/
acr.20257. - Zucker I, Yosipovitch G, David M, Gafter U, Boner G. Prevalence and characterization of
uremic pruritus in patients undergoing hemodialysis: uremic pruritus is still a major problem
for patients with end-stage renal disease. J Am Acad Dermatol. 2003;49:842–6. - Thombs BD, Hudson M, Taillefer SS, Baron M, Canadian Scleroderma Research Group.
Prevalence and clinical correlates of symptoms of depression in patients with systemic scle-
rosis. Arthritis Rheum. 2008;59(4):504–9. doi: 10.1002/art.23524. - Jewett LR, Hudson M, Malcarne VL, Baron M, Thombs BD, Canadian Scleroderma Research
Group. Sociodemographic and disease correlates of body image distress among patients with
systemic sclerosis. PLoS One. 2012;7(3), e33281. doi: 10.1371/journal.pone.0033281. - Knafo R, Thombs BD, Jewett L, Hudson M, Wigley F, Haythornthwaite JA. (Not) talking
about sex: a systematic comparison of sexual impairment in women with systemic sclerosis
and other chronic disease samples. Rheumatology (Oxford). 2009;48(10):1300–3.
doi: 10.1093/rheumatology/kep240. - Hudson M, Steele R, Lu Y, Thombs BD, Canadian Scleroderma Research Group, Baron
M. Work disability in systemic sclerosis. J Rheumatol. 2009;36(11):2481–6. doi: 10.3899/
jrheum.081237.
R.E. Pellar et al.